Priyanka Ganpatarav Pachunde
About Priyanka Ganpatarav Pachunde
Data last updated:
Priyanka Ganpatarav Pachunde is a Director at Nuclear Pharmaceuticals Private Limited (since 2017). The company operates in Trading. Nuclear Pharmaceuticals Private Limited reported revenue of ₹53.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nuclear Pharmaceuticals Private Limited U51909PN2017PTC169111 | Director | 27 Feb 2017 | 2017 | ₹53.5 Lakh (FY 2025) | Active |
Board colleagues of Priyanka Ganpatarav Pachunde
| Name | DIN | Company | Designation |
|---|---|---|---|
| Satish Ganpati Chavan | 07724330 | Nuclear Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Priyanka Ganpatarav Pachunde
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Priyanka Ganpatarav Pachunde
Priyanka Ganpatarav Pachunde currently holds 1 directorship: Nuclear Pharmaceuticals Private Limited (Director, since 27 Feb 2017, revenue ₹53.5 Lakh (FY 2025)).
Priyanka Ganpatarav Pachunde was first appointed on 27 Feb 2017 as Director at Nuclear Pharmaceuticals Private Limited.
The current boards of Priyanka Ganpatarav Pachunde's companies include Satish Ganpati Chavan (Nuclear Pharmaceuticals Private Limited).